Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

High‐resolution genomic and expression analyses of copy number alterations in breast tumors

Haverty, Peter M., Fridlyand, Jane, Li, Li, Getz, Gad, Beroukhim, Rameen, Lohr, Scott, Wu, Thomas D., Cavet, Guy, Zhang, Zemin, Chant, John·2008·Genes, Chromosomes and Cancer

Abstract

Analysis of recurrent DNA amplification can lead to the identification of cancer driver genes, but this process is often hampered by the low resolution of existing copy number analysis platforms. Fifty‐one breast tumors were profiled for copy number alterations (CNAs) with the high‐resolution Affymetrix 500K SNP array. These tumors were also expression‐profiled and surveyed for mutations in selected genes commonly mutated in breast cancer (TP53,CDKN2A,ERBB2,KRAS,PIK3CA,PTEN). Combined analysis of common CNAs and mutations revealed putative associations between features. Analysis of both the prevalence and amplitude of CNAs defined regions of recurrent alteration. Compared with previous array comparative genomic hybridization studies, our analysis provided boundaries for frequently altered regions that were approximately one‐fourth the size, greatly reducing the number of potential alteration‐driving genes. Expression data from matched tumor samples were used to further interrogate the functional relevance of genes located in recurrent amplicons. Although our data support the importance of some known driver genes such as ERBB2, refined amplicon boundaries at other locations, such as 8p11‐12 and 11q13.5‐q14.2, greatly reduce the number of potential driver genes and indicate alternatives to commonly suggested driver genes in some cases. For example, the previously reported recurrent amplification at 17q23.2 is reduced to a 249 kb minimal region containing the putative driver RPS6KB1 as well as the putative oncogenic microRNA mir‐21. High‐resolution copy number analysis provides refined insight into many breast cancer amplicons and their relationships to gene expression, point mutations and breast cancer subtype classifications. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045‐2257/suppmat. © 2008 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/gcc.20558

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 158

Metadata

Authors
Haverty, P. M., Fridlyand, J., Li, L., Getz, G., Beroukhim, R., Lohr, S., Wu, T. D., Cavet, G., Zhang, Z., & Chant, J.
Venue
Genes, Chromosomes and Cancer
Publisher
Wiley
Published
2008-03-11
Volume
47
Issue
6
Pages
530-542
ISSN
  • 1045-2257 (ISSN-L)
  • 1098-2264
OpenAlex
W2037416530
Cited by
158
References
3
FWCI
6.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High‐resolution genomic and expression analyses of copy number alterations in breast tumors. https://app.cochat.ai/papers/10.1002/gcc.20558
The paper
Haverty, P. M., Fridlyand, J., Li, L., Getz, G., Beroukhim, R., Lohr, S., Wu, T. D., Cavet, G., Zhang, Z., & Chant, J. (2008). High‐resolution genomic and expression analyses of copy number alterations in breast tumors. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.20558

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.